Aldeyra Therapeutics, Inc. (ALDX)
4.59
-0.20
(-4.18%)
USD |
NASDAQ |
Dec 11, 16:00
4.58
-0.01
(-0.22%)
After-Hours: 20:00
Aldeyra Therapeutics Free Cash Flow: -40.08M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Vanda Pharmaceuticals, Inc. | -82.95M |
| ADMA Biologics, Inc. | 40.61M |
| Exelixis, Inc. | 779.77M |
| Anavex Life Sciences Corp. | -39.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.021M |
| Cash from Investing (Quarterly) | 25.00M |
| Cash from Financing (Quarterly) | 0.1207M |
| Free Cash Flow Per Share (Quarterly) | -0.1168 |
| Free Cash Flow to Equity (Quarterly) | -7.009M |
| Free Cash Flow to Firm (Quarterly) | -6.546M |
| Free Cash Flow Yield | -14.58% |